Durvalumab vs Telmisartan

Durvalumab vs Telmisartan: Overview

This comparison examines the pharmacological differences between Durvalumab and Telmisartan.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Telmisartan: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Telmisartan — 24 hours.

Chemical Properties

Molecular Formula: Telmisartan — C33H30N4O2.

Molecular Weight: Telmisartan — 514.6230 g/mol.

Type: Durvalumab — Antibody; Telmisartan — Small molecule.